Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases
- PMID: 16010109
Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases
Abstract
Botulinum toxin is a new method for treating masseteric hypertrophy, which offers many advantages over conventional surgical treatment. We describe the successful outpatient medical management of two patients with masseteric hypertrophy using botulinum toxin type A. No significant side effects occurred and the patients were satisfied cosmetically six months after the treatment.
Similar articles
-
The medical management of masseteric hypertrophy with botulinum toxin.J Ir Dent Assoc. 2000;46(3):84-6. J Ir Dent Assoc. 2000. PMID: 11323940
-
The treatment of masseter hypertrophy with botulinum toxin type A.Saudi Med J. 2006 Mar;27(3):397-400. Saudi Med J. 2006. PMID: 16532107
-
[Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].Ned Tijdschr Geneeskd. 1998 Mar 7;142(10):529-32. Ned Tijdschr Geneeskd. 1998. PMID: 9623101 Dutch.
-
Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report.J Oral Maxillofac Surg. 1999 Aug;57(8):1017-9. doi: 10.1016/s0278-2391(99)90029-0. J Oral Maxillofac Surg. 1999. PMID: 10437733 Review. No abstract available.
-
Botulinum Toxin Injections for Masseter Reduction in East Asians.Dermatol Surg. 2019 Apr;45(4):566-572. doi: 10.1097/DSS.0000000000001859. Dermatol Surg. 2019. PMID: 30883483 Review.
Cited by
-
Botulinum toxin for masseter hypertrophy.Cochrane Database Syst Rev. 2013 Sep 9;2013(9):CD007510. doi: 10.1002/14651858.CD007510.pub3. Cochrane Database Syst Rev. 2013. PMID: 24018587 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources